No Data
Express News | Bayer Healthcare LLC Reports Passive Stake of 10.8% in Metagenomi as of Sept. 30 - Filing
Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
H.C. Wainwright Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $7
Reported Earlier, Metagenomi Shares Data On SMART Gene Editing Platform At AIChE Conference, Emphasizing AAV Packaging
We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully
No Data
No Data